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Summary: The neutral sugars and hcxosamines in the seromucoid fraction of normal human serum were
identified and determined simultaneously by gas-liquid chromatography of their aldononitrilc acctates. Be-
sidcs the sialic acid, normal seromucoid contained fucose, arabinose, mannosc, glucose, galactose, glucosam-
ine and galactosamine. The presence of arabinose and glucose, not previously reported in seromucoid, äs well
äs the other known carbohydrate components determined by GLC were confirmed from their fragmentation
patterns in the electron impact mass spectra and chemical ionization spcctra.
Die Protein-gebundenen Kohlenhydrate von Seromucoid aus normalem Serum des Menschen
Zusammenfassung: Die Neutralzucker und Hexosamine in der Seromucoidfraktion aus normalen Serum des
Menschen wurden durch Gaschromatographie ihrer Aldononitrilacetate identifiziert und gleichzeitig be-
stimmt. Neben Neuraminsäure enthielt normales Seromucoid Fucose, Arabinose, Mannose, Glucose, Galak-
tose, Glucosamin und Galaktosamin. Das bisher nicht mitgeteilte Vorkommen von Arabinose und Glucose in
Seromucoid als auch die anderen durch Gaschromatographie bestimmten Kohlenhydrat-Komponenten
wurden durch ihre Fragmentierungsmuster im Elektronenstoß- und chemischen lonisations-Massenspektrum
bestätigt.
Introduction
Seromucoids are the carbohydrate-protein conju-
gates in serum, which are soluble in 0.6 mol/1 per*
chloric acid but are insoluble in phosphotungstic
.acid. These consist, predominantly, of the carbohy-
drate-rich glycoprotein fraction called the "acute
phase reactants". These acute phase reactants are
very labile to stress situations and are produced in
increased quantitics in the liver parenchymal cells
and are poured into the blood stream in infection,
trauma and inflammatory, degenerative and neo-
plastic diseases (1). The response pattern of the in-
creased biosynthesis of this heterogenous group of
trauma-inducible glycoproteins may differ consider-
ably in various clijiical conditions and Stresses. Thus,
the glycoproteins in seromucoid fraction may appcar
in blood in different extents in various types of injur-
ies to the tissues. A part of the glycoproteins in the
seromucoid fraction also arises from the intercellular
matrix of the connective tissue (2), which itself is in-
fluejnced by several physiological and pathological
states, including tissue destruction, tissue prolifera-
tion, wound healing, cancer, etc. (3). Analyses of the
seromucoids for diagnostic uses are commonly car-
ried out by turbidimetric (4), immunological (5) and
spectrophotometric (6) methods. The spectrophoto-
metric methods are based upon the fact that the se-
romucoid fraction is glycoprotcin in nature and its
levels have been measured äs total protein or tyro-
sinc or äs its protcin-bound carbohydrate residucs
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measured äs total fucose, total hexose, hexosamine
or sialic acid (6-8). However, it has been found that
the solubility of the various seromucoid fractions in
perchloric acid and the protection of the perchloric
acid-soluble fraction from coprecipitation with pro-
teins in phosphotungstic acid depend uport the na-
ture and amounts of the covalently-bound carbohy-
drate residues (9). Since the carbohydrate composi-
tion of the different seromucoid fractions is not the
same, a complete analysis of the individual carbohy-
drate components could provide more useful infor-
mation on the seromucoids. This paper describes the
complete carbohydrate composition of the seromu-
coids isolated from normal human serum.
(b) The ampoule was cooled to room temperature and after care-
fully breaking the tip, 0.2 ml of a freshly prepared solution (500 g/
1) of sodium nitrite was added. The ampoule was resealed keeping
the flame away from its contents. Vortexing for 25-30 min com-
pleted the deamination of hexosamines (2-amino-2-deoxyhex-
oses) to anhydrosugars (10, 11).
(c) The tip of the ampoule was broken and the .pH of its contents
adjusted to 5-6 with a pinch of AG1 X-2 (HCOl resin).This
solution was deionized by passing it through a tandem arfange-
ment of twp columns made from 10 ml disposable glass pipettes.
The upper column (1x4 cm) was packed with AG 50W-X8 (H+,
100-200 mesh) resin and it drained irito a lower (l x 5 cm) co-
lumn packed with AG l X-2 (HCOl) resin. About 70-75 ml of
eluate and the water washings were collected and reduced to a
l—2 ml volume in a rotary evaporator at room temperature. This
solution was transferred quantitatively into a 10ml ampoule and
the solution was lyophilized.
Materials and Methods
Materials
Serum was obtained from blood drawn from healthy, male, Cauc-
asian hospital employees between the ages of 22—55 years. The
sugars used äs Standards were purchased from Sigma Chemical
Co., St. Louis, Missouri. The ion-exchange resins AG 1-X2
(CPform, 200-400 mesh) and AG50W-X8 (H+, 100-200
mesh) were obtained from BioRad Laboratories, Richmond, Cali-
fornia. The anion-exchange resin AG 1-X2 (HCOl form) was
prepared from AG 1-X2 (CPform) by packing this resin in a co-
lumn and sequentially washing with 2 mol/1 sodium hydroxide,
distilled water, 22 mol/i sodium hydrogen carbonate and distilled
water. The acetylating kit containing pyridine and acetic anhy-
dride was supplied by Applied Science Laboratories, State Col-
lege, Pennsylvania. Inositol used äs the internal Standard was pur-
chased from Difco Laboratories, Detroit, Michigan.
Precipitation of seromucoid
To 2.5 ml of serum, contained in a 50 ml centrifuge tube, 22.5 ml
of 8.5 g/l sodium Chloride solution were added. After a slow addi-
tion of 12.5 ml of 1.8 mol/1 perchloric acid with intermittent shak-
ing and waiting for 10 minutes, the mixtures was filtered through a
Whatman No. 50 filter paper. To 25 ml of this filtrate, 5 ml of a
50 g/l phosphotungstic acid solution were added. Following mix-
ing by vortexing and after 10 minutes, the seromucoid precipitate
was collected by centrifugation for 10 minutes at 4°C and
2000 min"1. The precipitate was dried in a vacuum oven at room
temperature and dissolved in 0.25 ml of distilled water and repre-
cipitated with l ml of 950 ml/l ethanol. the precipitate was trans-
ferred quantitatively into a 10 ml glass ampoule with 3ml of
950 ml/l ethanol, using l ml aliquots. The mixture in the ampoule
was vortexed and centrifuged at 2000 min·"1 for 10 minutes. After
removing the supernatent, the precipitate was washed two more
times with 3 ml of 950 ml/l ethanol to remove perchloric acid and
any possible carbohydrate contaminants in seromucoid.
Isolation of neutral and amino sugars
It was carried out by the following Steps:
(a) The°precipitate in the ampoule was dissolved by adding 0.5 ml
of 0.1 mol/1 NaOH and l ml of distilled water and vortexing. To
this solution 50 of myoinositol (internal Standard) solution
(0.2 g/l) and 0.15 ml of conc. HC1 were added and after deaera-
tion with N2 for 5 min, the ampoule was seäled tightly and placed
in an oven at 100 °C for 4 hours.
Perivatization for gas ehfpmätography
The residue in the ampoule was dried for 10 min. in a vacuum
oven and the aldoses and the 2,5-anhydrosugars; formed by
deamination of hexosamines (10), were converted into their
aldononitrile acetates by heating With hydroxylamine hydfpchlP-
ride (3—4 mg) and pyridine (5 drops), and läter with acetic anhy-
dride (15 drops) äs described previously (l 1). The derivatized and
washed (12) residue was dissolved in 25 of Chloroform and 5
were injected into the gas Chromatograph.
Preparation of Standards
A 4 ml Standard solution was prepared, which contained 8 mg of
each of L-rhamnose (== 8.8772 mg L-rhamnose · H^Ö), L-fucose,
L-arabinose, D-xylpse and 16mg of each of D-mannose, D-glu-
cpse, D-galactose äs well äs D-glucosamine and D-galactosamine
(= 19.2586 mg of their hydrochlorides). A 0.1 ml aliquot Pf thi$
Standard solution was mixed with 100 of myoinositol solution
(2 g/l) and freeze dried. It was subjected to the aforementiöned
Steps (a)-(c) for Isolation and derivatization used for the seromu-
coid sample. However, the various reagents used were: for deami-
nation of hexosamines, sodium nitrite solution (500 g/l) 0.3 ml;,
for derivatization, hydroxylamine hydrochloride 12^14 mg, pyri-
dine 15 drops and acetic anhydride 45 drops., The derivatized and
washed (12) residue was dissolved in 0.5 ml of Chloroform aiid
5 of this solution were used for gas ehromätography.
Gas ehromätography
A series 1200 Varian Aerograph equipped with a flame ionization
detector and a 3380 A Hewlett Packard Computing integrator was
used. A stainless steel column (9 ft. x 1/8 in., i.d.) packed with
3% poly (neopentylglycol süccinate) on öas Chrom Q (100/120
mesh, Applied Science Labs., State College, Pa.) was used. The
injector and detector temperatures were 130 °C and 230 PC, re-
spectively. The column temperature was programmed
130-195 °C at l °C/min and the camer gas used was nitrogen at a
flow rate of 45 ml/min.
Sialic acid analysis
The 0.5 ml sämples of the sera were diluted with 4.5 ml of 8.5 g/l
sodium chloride solution and 2.5 ml of 1.8 mol/1 perchloric acid
were added with shaking. After 10 min, the supernatant was cen-
trifuged off and 1.0 ml of 50 g/l phosphotungstic acid was added
to this supernatant. After shaking and allowing to stand for 10
min, centrifugation, inverting the centrifuge tube for a while, the
precipitate was dissolved in 0.33 ml of 0.1 möl/1 NaOH. After di-
lution w*ith 3 ml Pf water, the sialic acid was determinedin 1.0ml
of this solution using the diphenylamine reaction (6).
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Electron impact-chemical ionization mass spectrome-
try
These analyses were carried out in the Food Science and Human
Nutrition Department of the University of Florida. Both the elec-
tron impact and chemical ionization spectra were recorded on a
Finnigan Model 4021 Instrument, which includes a data System.
The gas Chromatograph was fitted with a glass column (Finnigan
9610, 6 ft x 2 mm i.d. x 4 in) packed with 3% poly (neopentyl-
glycol succinate) on Gas Chrom Q (100/120 mesh, Applied
Science Laboratories, State College, Pa.). The aldononitrile ace-
tates of the neutral sugars and 2,5-anhydrohexoses (from deami-
nation of hexosamines) were eluted isothermally at 215 °C with
helium äs the carrier gas at a flow rate of 20 ml/min. In the elec-
tron impact mode, the Instrument was operated at an inlet
temperature of 225 °C, an ionization potential of 70 eV and an ion
source temperature of 300 °C. For analysis by the quadropole
mass spectrometer in the chemical ionization mode, the method of
Li et al. (13) was slightly modified. In the chemical ionization
mode, the Instrument was operated at a source temperature of
150 °C, and ionization potential of 55 eV, a füament emission cur-
rent of 0.3 mA, an accelerating voltage of -4V, and the isobutane
reagent gas pressure of 5 10"5 torr. About 1100 spectra were
recorded for analysis and comparison during a typical 90 minute
isothermal Chromatographie Separation,
Results and Discussion
The GLC of the aldononitrile acetates of the neutral
sugars and the 2,5-anhydrohexoses formed from
deamination of the hexosamines in the hydrolyzates
of the normal human seromucoids showed the pres-
ence of fucose, arabinose, mannose, glucose, galac-
tose, glucosamine and galactosamine. Figure l a
5 7
10
0 10 20 30 '40 50 60 70 80
Retention t i ine [min]
Fig. 1. Gas Chromatographie Separation *öf aldononitrile acetates
of neutral sugars and deaminated hexosamines.
a) Standard mixture,
b) normal human seromucoid',
Peaks äre:
1, rhamnose;
2, fucose;
3, arabinose;
4, xylose;
,5, glucosamine;
7, niannose;
8, giucpse;
9, galactose;
10, inositol.
shows the GLC Separation of the Standard sugars. A
typical Chromatographie Separation of the carbohy-
drate residues in the normal seromucoid hydroly-
zates is shown in figure Ib. The quantitative values
(mg/1) of these individual carbohydrate components,
in terms of their ranges and mean ±S.D., are given
in table 1. The sialic acid contents of these seromu-
coids deterrnined by spectrophotometry were 173.1
± 27.4 mg/1.
Tab. 1. Carbohydrate composition of seromucoid from 20 nor-
mal human subjects.
Component
Fucose
Arabinose
Mannose
Glucose
Galactose
Glucosamine
Galactosamine
Sialic Acid
Range
(mg/1)
1.3-
1.0-
9.1 -
6.0-
12.1 -
33.8-
1.3-
148.0 -
3.0
2.3
27.0
29.0
53.0
75.0
4.4
209.0
Levels (mg/1)
Mean ± S.D.
2.0 ± 0.1
1.6 ± 0.3
18.6 ± 7.9
16.9 ± 9.3
33.3 ± 17.3
58.1 ± 16.4
3.5 ± 2.1
173.1 ± 27.4
In addition to the Chromatographie retention times,
the electron impact and chemical ionization mass
spectra provided evidence for the identities of arabi-
nose and glucose, not mentioned in literature, äs well
äs the previously reported carbohydrate residues: fu-
cose, mannose, galactose, glucosamine and galactos-
amine in the hydrolyzates of normal human seromu-
coid. The electron impact mass spectra for arabinose
and glucose gave typical spectra indicative of these
sugars but the definitive parent mass ions were not
present. Chemical ionization-mass spectrometry
provided an unambiguoüs identification of arabinose
and glucp$e in the sample. The spectra obtained at
scari 240 (fig. 2ä) clearly shows the M+1 species
which is characteristic of peracetylated arabinonitrile
to which a proton has been added. Although the scan
820 did not yieid the M+l ion for the glucose deriv-
ative, the presence of the expected large contribu-
tipns from mass 328 was characteristic of glucose, äs
reported by Li et al. (13).
The mass chromatogram of figure 2 shows three
peaks with substantial mass 256 contributions which
is characteristic of pentoses. The mass chromato-
gram for mass ion 316 derived-from peracetylated
arabinonitrile shows a peak at scans 238—240
(fig. 2c). The peak of mass 372 in scan 240 (fig. 2d)
is due to reaction of the arabinose derivative with the
isobutyl ion (C4H9+). Thus the chemical ionization
mass spectrum obtained at scan 240 (fig. 2a) con-
firms the presence of arabinose by three highly char-
acteristic mass ions, i.e. 256, 316 (M+l), and 372
(M+57).
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Fig. 2a-2d. Chemical ionization mass spectral identification of
arabinose (see text). Figs. 2b, 2c, and 2d represent
scans of the mass fragments of 256, 316, and 372
m/e, respectively.
Seromucoids form only a small fraction of the serum
glycoproteins but are comparatively richer in car-
bohydrates. These constitute a heterogenous mix:
ture of the acute phase reactants, which include the
oii-acid glycoprotein, -antitrypsin, haptoglobin, ce-
ruloplasmin and haemopexin. Since the acute phase
reactants originale in serum both from biosynthesis
in liver (1) and the intercellular matrix of the tissues
(2, 3), non-specific increases occur due to an en-
hanced hepatic synthesis in inflammatory and prolif-
erative conditions äs well äs increased tissue break-
down in fever and in other pathological states. The
amounts and types of seromucoids elevated, howev-
er, may vary in tissue destruction, proliferation or
inflammation (1). Also, these levels would be affect-
ed by glomerular filtration and tubular reabsorption
(14) and would, therefore, be altered in renal condi-
tions. The seromucoid levels would be the net result
of their synthesis in liver and their removal from
blood into urine. Thus, decreased seromucoid levels
(measured äs protein-bound hexose) häve been ob-
served in diffuse parenchymatous liver diseases like
cirrhosis due to decreased synthesis and also in
nephrotic syndrome due to increased elimination of
seromucoids in urine (6).
The seromucoid levels in sera are related to the se-
rum glycoprotein fractions affected in disease, which
in turn would be related to the carbohydrate coinpo-
sition of the affected fractions (9). In general, the
higher the carbohydrate Contents of these fractions,
the higher is their solubility in perchloric acid and
the higher would be the quantities of seromucoid
recovered in the phosphotungstate precipitate (15).
Not only the amount of the carbohydrate residues
but also the nature of these residues in the seromu^
coid fractions influences the quäntity of the precipit-^
able seromucoid. For an example, the removal of si-
alic acid with the enzyme neuraminidase (EC
3.2.1.18) decreases the quäntity of seromucoid pre-
cipitated with phosphotungstate (15). Thus, mea-
surements of the individual components öf neutral
sugars, hexosamines and sialic acid would give a bet-
ter picture öf the seromucoid chänges for diagnosis
and prognosis of a disease process than just the mea-
surement of the total precipitable material or a mear
surement of total fucose or sialic acid or total hexose
or tyrosine contents of the seromucoid.
The precision of the anälysis of the carbohydrate
cömponeiits öf normal human seromucoid was de^
termined by analyzing the same pöpl of the human
seromucoid six different times. Table 2 gives the
means, S.D.s^ and the coefficients of Väriations
(C.V.s) for the individual carbohydrate components.
Low C.V.s süggest a high pfecision of the analyses.
Tab. 2. Estirhation of precision of anälysis of carbohydrate com-
ponents in normal human sefocnucpid pool (n = 6).
Component
Fucose
Arabinose
Mannose
Glucose
Galactose
Glucosamine
Galactosamine
Sialic acid
Mean
(mg/1)
2.6
2.0
19.9
5.1
29.6
58.8
1.3
165.9
S.D.
0.1
0.06
0.8
0.3
1.2
3.0
0.1
4.6
C.V.(%)
5.49
3.02
4.35
6.25
4.05
5.14
8.50
2.78
The seromucoid is heterogenoüs electrophoretically
and immuno-electrophoretically (16). It consists lar-
gely of the aracid glycoprotein (orosomucoid),
which in human blood has been found by direct iso-
lation methods to be preserit ät ä concentration of
0.2-0.4 g/l (17) and at 0.91 g/l by Manäni]s immu-
nochenucal method (18). Although several fractions
other than the ai-acid glycoprötein äre also present
in seromucoid in smaller amounts, the majority of
the physical, biological and chemieal studies have
been concentrated on the formet fraction isolated
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from human and animal sera. Analyses of the ai-acid
glycoprotein by several investigators have shown a
wide r nge in the carbohydrate composition and no
pentose has been reported s its component (18).
Also, although glucose has been detected in serum
glycoproteins using G.L.C. (19) and mass-spec-
trometry (20), no glucose has been determined in
the purified α ι-arid glycoprotein. The lack of arabi-
nose and glucose in the αι-acid glycoprotein may in-
dicate that these sugar residues are probably present
in some minor fraction/s other than the αι-acid gly-
coprotein fraction of the human seromucoid.
The presence of the pentose, arabinose, reported by
different investigators in hyaluronic acid prepara-
tions from different mammalian sources has been re-
viewed elsewhere (21). Earlier reports on the pres-
ence of arabinose s a component of bovine brain
hyaluronic acid were contested (22) and later its
presence was established (23) upon confirmation by
Chromatographie, enzymatic and mass-spectrometric
and chemical-ionization methods. Recently, Longas
& Meyer (24) using sequential hydrolysis of the
rooster comb hyaluronic acid with a mixture of glyc-
osidases detected only <0.02% neutral sugars in the
hydrolyzate. This surprisingly low neutral sugar con-
tent, s compared to the contents reported by other
investigators in hyaluronates from other tissue sour-
ce$, is difficult to explain. It may be attributable to
the method of preparation of the rooster comb hya-
luronate or to this tissue source being different from
those used by other investigators.
The immunological studies have been reported only
on the α r acid glycoprotein fraction of seromucoid.
This seromucoid fraction is weekly antigenic when
injected in chickens and rabbits (17) and it gives a
single, well-defined precipitin line on immunoelec-
trophoresis (16, 25). However, its electrophoresis at
pH 5 resolves it into two variants, which are
immunochemically identical (26). The antigenic
property of this seromucoid fraction resides only in
the protein part and not in its carbohydrate chain,
since periodate oxidation destroys the carbohydrate
residues without affecting its antigenicity (16, 17).
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